Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder

Brain Research

Volumn 1467, Issue , 2012, Pages 91-103

  Mc Fie, Sarah ^a   Sterley, Toni Lee ^a   Howells, Fleur M ^a   Russell, Vivienne A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

1 Adrenoceptor; ADHD; Clozapine; Noradrenaline; SHR

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE 4 RECEPTOR; GLUTAMIC ACID; NORADRENALIN; POTASSIUM; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENETIC PREDISPOSITION; HIPPOCAMPUS; ISOTOPE LABELING; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; CLOZAPINE; EXPLORATORY BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; NOREPINEPHRINE; POTASSIUM; PREFRONTAL CORTEX; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

ANIMALIA; RATTUS;

EID: 84863983651     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.05.047     Document Type: Article

References (104)

1. D.J. Abrams, L. Zheng, K.S. Choo, J.J. Yang, W. Wei, T.J. Anchordoquy, N.H. Zawia, and K.E. Stevens An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients Schizophr. Res. 100 2008 86
2. J. Alvir, J. Lieberman, A. Safferman, J. Schwimmer, and J. Schaaf Clozapine-induced agranulocytosis N. Engl. J. Med. 329 1993 162 167
3. K.O.K. Aoki Development of a strain of spontaneously hypertensive rats Circ. J. 27 1963 282 293
4. J.G. Auerbach, J. Benjamin, M. Faroy, and V. Geller DRD4 related to infant attention and information processing: a developmental link to ADHD? Psychiatr. Genet. 11 2001 31 35 (Pubitemid 32499860)
5. R.J. Baldessarini, F. Centorrino, J.G. Flood, S.A. Volpicelli, D. Huston-Lyons, and B.M. Cohen Tissue concentrations of clozapine and its metabolites in the rat Neuropsychopharmacology 9 1993 117 124 (Pubitemid 23275837)
6. T. Baptista, A. Mata, L. Teneud, De Quijada Mary, H. Han, and L. Hernandez Effects of long-term administration of clozapine on body weight and food intake in rats Pharmacol. Biochem. Behav. 45 1993 51 54
7. M.A. Bellgrove, Z. Hawi, N. Lowe, A. Kirley, I.H. Robertson, and M. Gill DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and - 521 SNP Am. J. Med. Genet. 136B 2005 81 86 (Pubitemid 40917534)
8. R. Blanc, A. Ville, J. Glowinski, and J. Tassin Critical role of a1-adrenergic receptors in acute and sensitized locomotor effects of d-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics Synapse 43 2002 51 61 (Pubitemid 33115667)
9. F. Boix, S. Qiao, T. Kolpus, and T. Sagvolden Chronic l-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit/hyperactivity disorder Behav. Brain Res. 94 1998 153 162 (Pubitemid 28352471)
10. G. Bonanno, and M. Raiteri Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain Synapse 1 1987 254 257 (Pubitemid 17120918)
11. M. Bourin, B. Guitton, E. Dailly, P. Hery, and P. Jolliet A follow-up study of a population of schizophrenic patients treated with clozapine Prog. Neuropsychopharmacol. Biol. Psychiatry 25 2001 1481 1495 (Pubitemid 33042692)
12. Y. Braw, O. Malkesman, M. Dagan, A. Bercovich, Y. Lavi-avnon, and M. Schroeder Anxiety-like behaviors in pre-pubertal rats of the Flinders Sensitive Line (FSL) and Wistar-Kyoto (WKY) animal models of depression Behav. Brain Res. 167 2006 261 269 (Pubitemid 43099788)
13. J. Bruhwyler, E. Chleide, J. Liegeois, J. Delarge, and M. Mercier Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test Pharmacol. Biochem. Behav. 36 1990 57 61 (Pubitemid 20165635)
14. M.B. Calzavara, A. Medrano, R. Levin, S.R. Kameda, M.L. Andersen, S. Tufik, H. Silva, and R. Frussa-filho Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia? Schizophr. Bull. 35 2009 748 759
15. T.J. Collier, J.G. Greene, D.L. Felten, S.Y. Stevens, and K. Steece Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats Cell. 25 2004 209 221 (Pubitemid 38121694)
16. D.E. Comings, B.G. Comings, D. Muhleman, G. Dietz, B. Shahbahrami, D. Tast, E. Knell, P. Kocsis, R. Baumgarten, B.W. Kovacs, D.L. Levy, M. Smith, R.L. Borison, D.D. Evans, D.N. Klein, J. MacMurray, J.M. Tosk, J. Sverd, R. Gysin, and S.D. Flanagan The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders JAMA 266 1991 1793 1800
17. D.A. Daly, and B. Moghaddam Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats Neurosci. Lett. 152 1993 61 64 (Pubitemid 23149313)
18. S.F. De Boer, and J. Van Der Guguten Daily variations in plasma noradrenaline, adrenaline and corticosterone concentrations in rats Physiol. Behav. 40 1987 323 328 (Pubitemid 17105271)
19. W. De Jong, A. Linthorst, and H. Versteeg The nigostriatal dopamine system and the development of hypertension in the spontaneously hypertensive rat Arch. Mal. Coeur Vaiss. 88 1995 1193 1196
20. R. De La Garza, and J. Mahoney A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression Brain Res. 1021 2004 209 218
21. A. Delina-Stula, and C. Hunn Neophobia in spontaneously hypertensive (SHR) and normotensive control (WKY) rats Behav. Neural Biol. 43 1985 206 211 (Pubitemid 15142872)
22. S.L. Dickinson, B. Gadie, I.F. Tulloch, D. Lane, and N. Humberside And 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat Eur. J. Pharmacol. 96 1988 521 527 (Pubitemid 19002230)
23. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data Behav. Brain Res. 31 1988 47 59
24. L. Farde, F. Wiesel, A. Nordstrom, and G. Sedvall D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics Psychopharmacology (Berl) 99 1989 S28 S31
25. D. Farnbach-Pralong, R. Bradbury, D. Copolov, and D. Brian Clozapine and olanzapine treatment decreases rat cortical and limbic GABAA receptors Eur. J. Pharmacol. 349 1998 R7 R8
26. A. Fassio, F. Rossi, G. Bonanno, and M. Raiteri GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels J. Neurosci. Res. 57 1999 324 331 (Pubitemid 29339788)
27. S.A. Ferguson, and A.M. Cada A longitudinal study of short- and long-term activity levels in male and female spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats Behav. Neurosci. 117 2003 271 282 (Pubitemid 36384246)
28. S.A. Ferguson, and A.M. Cada Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rat strains Pharmacol. Biochem. Behav. 77 2004 583 594 (Pubitemid 38296819)
29. S.A. Ferguson, and E.P. Gray Aging effects on elevated plus maze behavior in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male and female rats Physiol. Behav. 85 2005 621 628 (Pubitemid 41139270)
30. 3H-norepinephrine release in hypothalamic, preoptic area and cortical slices of female rats Science 31 1997 769 780 (Pubitemid 27493965)
31. V. Fischer, U. Schmitt, H. Weigmann, R.C. Hiemke, N. Dahmen, U. Schmitt, H. Weigmann, B. Keller, S. Reuss, and C. Hiemke Haloperidol and clozapine treatment in rats: differential RNA display analysis, behavioural studies and serum level determination Prog. Neuropsychopharmacol. Biol. Psychiatry 22 1998 1129 1139 (Pubitemid 28511590)
32. C. Gentsch, M. Lichtsteiner, and H. Feer Open field and elevated plus-maze: a between, open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide Behav. Brain Res. 25 1987 101 107 (Pubitemid 17137690)
33. G. Griebel, C. Belzung, R. Misslin, and E. Vogel The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobic reducing drugs Behav. Pharmacol. 4 1993 637 644 (Pubitemid 24002278)
34. L. Hawk, A. Yartz, W. Pelham, and T. Lock The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder Psychopharmacology (Berl) 165 2003 118 127 (Pubitemid 36056988)
35. E. Herlenius, and H. Lagercrantz Development of neurotransmitter systems during critical periods Exp. Neurol. 190 2004 8 21
36. F.M. Howells, and V.A. Russell Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/ hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety- like behaviours (Wistar-Kyoto rat) Brain Res. 1200 2008 107 115
37. F.M. Howells, L. Bindewald, and V.A. Russell Cross-fostering does not alter the neurochemistry or behavior of spontaneously hypertensive rats Behav. Brain Funct. 11 2009 5 24
38. F.M. Howells, D. Stein, and V.A. Russell Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance Metab. Brain Dis. 2012 (Epub ahead of print)
39. G.B. Jensen, G.H. Collier, and M.B. Medvin A cost-benefit analysis of nocturnal feeding in the rat Physiol. Behav. 31 1983 555
40. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic Arch. Gen. Psychiatry 45 1988 789 796
41. S. Knardahl, and T. Sagvolden Open-field behavior of spontaneously hypertensive rats Behav. Neural Biol. 200 1979 187 200 (Pubitemid 10192099)
42. J. Knauber, and W.E. Muller Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the a 1b-adrenoceptor Eur. Neuropsychopharmacol. 10 2000 423 427
43. M.J. Kofler, and M.D. Rapport ADHD and working memory: the impact of central executive deficits and exceeding storage/rehearsal capacity on observed inattentive behavior J. Abnorm. Child Psychol. 38 2010 149 161
44. S.K. Kulkarni, K. Singh, and M. Bishnoi Comparative behavioural profile of newer antianxiety drugs on different mazes Indian J. Exp. Biol. 46 2008 633 638
45. D. Leo, E. Sorrentino, F. Volpicelli, M. Eyman, D. Greco, D. Viggiano, U. di Porzio, and C. Perrone-Capano Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD Neurosci. Biobehav. Rev. 27 2003 661 669 (Pubitemid 37414914)
46. R. Levin, M. Bendlin, C. Mauricio, W. Agostini, S. Tamie, and V. Costhek Spontaneously hypertensive rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine Prog. Neuropsychopharmacol. Biol. Psychiatry 2011 6 10
47. Q. Li, G. Lu, G.E. Antonio, Y.T. Mak, J.A. Rudd, M. Fan, and D.T. Yew The usefulness of the spontaneously hypertensive rat to model attention-deficit/ hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain Neurochem. Int. 50 2007 848 857 (Pubitemid 46722647)
48. Q. Li, J. Wong, G. Lu, G. Antonio, D. Yeung, T. Ng, L. Forster, and D. Yew Gene expression of synaptosomal-associated protein 25 (SNAP-25) in the prefrontal cortex of the spontaneously hypertensive rat (SHR) Mol. Basis Dis. 1792 2009 766 776
49. I. Manor, M. Corbex, J. Eisenberg, I. Gritsenkso, R. Bachner-melman, S. Tyano, and R.P. Ebstein Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA) Am. J. Med. Genet. 127B 2004 73 77 (Pubitemid 38542317)
50. J.M. Manzaneque, P.F. Brain, and J.F. Navarro Effect of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 349
51. M.T. Martin-Iverson, M. Pisa, E. Chan, and H.C. Fibiger Enhanced neophobia but normal plasma corticosterone levels in rats with dorsal noradrenergic bundle lesions Pharmacol. Biochem. Behav. 17 1982 639 643 (Pubitemid 13208415)
52. S.T. Mason, and H.C. Fibiger Altered exploratory behaviour after 6-OHDA lesion to the dorsal noradrenergic bundle Nature 269 1977 704 705 (Pubitemid 8186759)
53. R. McCarty, and I.J. Kopin Patterns of behavioral development in spontaneously hypertensive rats and Wistar-Kyoto normotensive controls Dev. Psychobiol. 12 1979 239 243 (Pubitemid 9141239)
54. A. Mead, M. Li, and S. Kapur Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide Pharmacol. Biochem. Behav. 90 2008 551 562
55. M. Melone, L. Vitellaro-Zuccarello, A. Vallejo-Illarramendi, C. Matute, A. Cozzi, D. Pellegrini-Giampietro, J. Rothstein, and F. Conti The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine Mol. Psychiatry 6 2001 380 386 (Pubitemid 32566086)
56. A. Meneses, T. Ponce-lopez, R. Tellez, R. Gonzalez, C. Castillo, and A. Gasbarri Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats Behav. Brain Res. 216 2011 472 476
57. M.M. Myers, R.E. Musty, and E.D. Hendley Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine Behav. Neural Biol. 54 1982 42 54 (Pubitemid 12101057)
58. S. Nayak, and H.J. Cassaday The novel dopamine D 4 receptor agonist (PD 168, 077 maleate): doses with different effects on locomotor activity are without effect in classical conditioning Prog. Neuropsychopharmacol. 27 2003 441 449 (Pubitemid 36403735)
59. M.F. O'Neill, C.L. Heron-Maxwell, and G. Shaw 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB Pharmacol. Biochem. Behav. 63 1999 237 243 (Pubitemid 29234102)
60. S. Pallanti, L. Quercioli, A. Rossi, and A. Pazzagli The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation J. Clin. Psychiatry 60 1999 819 823
61. S. Pallanti, L. Quercioli, and A. Pazzagli Social anxiety and premorbid personality disorders in paranoid schizophrenic patients treated with clozapine CNS Spectr. 5 2000 29 43
62. M.C. Pardey, J. Homewood, A. Taylor, and J.L. Cornish Re-evaluation of an animal model for ADHD using a free-operant choice task J. Neurosci. Methods 176 2009 166 171
63. M.C. Pardon, G.G. Gould, A. Garcia, L. Phillips, M.C. Cook, S.A. Miller, P.A. Mason, and D.A. Morilak Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders Neuroscience 115 2002 229 242 (Pubitemid 35232702)
64. W.P. Pare Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats Physiol. Behav. 55 1994 433
65. L. Park, J.T. Nigg, I.D. Waldman, K.A. Nummy, M. Rappley, and K.H. Friderici Association and linkage of a-2A adrenergic receptor gene polymorphisms with childhood ADHD Mol. Psychiatry 2005 572 580 (Pubitemid 40897041)
66. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167 (Pubitemid 16239568)
67. V.A. Pires, F.A. Pamplona, P. Pandolfo, R.D.S. Prediger, and R.N. Takahashi Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD) Behav. Brain Res. 215 2010 39 44
68. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur. J. Pharmacol. 463 2003 3 33 (Pubitemid 36205070)
69. G. Rammes, B. Eisensamer, U. Ferrari, M. Shapa, G. Gimpl, K. Gilling, C. Parsons, K. Riering, F. Holsboer, and R. Rupprecht Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner Mol. Psychiatry 2004 846 858 (Pubitemid 39273534)
70. A. Ramos, O. Berton, P. Mormede, and F. Chaouloff A multiple-test study of anxiety-related behaviours in six inbred rat strains Behav. Brain Res. 85 1997 57 69 (Pubitemid 27116150)
71. G.V. Rebec, C.P. Grabner, M. Johnson, R.C. Pierce, and M.T. Bardo Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty Neuroscience 76 1997 707 714 (Pubitemid 27013411)
72. E. Richelson, and T. Souder Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds Life Sci. 68 2000 29 39
73. H. Rollema, Y. Lu, A.W. Schmidt, and S.H. Zorn Clozapine increases dopamine release in prefrontal cortex by 5-HT 1A receptor activation Eur. J. Pharmacol. 1997 1996 1998
74. L.A. Rosario, and E.D. Abercrombie Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats Brain Res. 48 1999 595 602 (Pubitemid 29264827)
75. V.A. Russell Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat Behav. Brain Res. 130 2002 191 196 (Pubitemid 34195335)
76. V. Russell, S. Allie, and T. Wiggins Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention/deficit hyperactivity disorder - the spontaneously hypertensive rat Behav. Brain Res. 117 2000 69 74
77. T. Sagvolden Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD) Biobehav. Rev. 24 2000 31 39 (Pubitemid 30026144)
78. T. Sagvolden, M.A. Metzger, H.K. Schoirbeck, A. Rugland, I. Spinnangr, and G. Sagvolden The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants Behav. Neural Biol. 58 1992 103 112
79. T. Sagvolden, M.B. Pettersen, and M.C. Larsen Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains Physiol. Behav. 54 1993 1047 1055 (Pubitemid 23343120)
80. T. Sagvolden, H. Aase, P. Zeiner, and D. Berger Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder Behav. Brain Res. 94 1998 61 71 (Pubitemid 28352465)
81. T. Sagvolden, V.A. Russell, H. Aase, E.B. Johansen, and M. Farshbaf Rodent models of attention-deficit/hyperactivity disorder Biol. Psychiatry 57 2005 1239
82. S.J. Sara, C. Dyon-laurent, and A. Herd Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system Cogn. Brain Res. 2 1995 181 187
83. U. Schmitt Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior Prog. Neuropsychopharmacol. Biol. Psychiatry 22 1998 1197 1215 (Pubitemid 28511595)
84. P. Seeman, R. Corbett, and Van Tol Hubert Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors Neuropsychopharmacology 16 1997 93 110 (Pubitemid 27088199)
85. P. Simon, R. Dupuis, and J. Costentin Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions Behav. Brain Res. 61 1994 59 64 (Pubitemid 24097017)
86. A.M. Snoddy, and R.E. Tessel Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice Eur. J. Pharmacol. 116 1985 221 228 (Pubitemid 16191811)
87. C.F. Spurney, S.M. Baca, A.M. Murray, G.E. Jaskiw, J.E. Kleinman, and T.M. Hyde Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats Synapse 34 1999 266 276 (Pubitemid 29523133)
88. T. Sterley, F.M. Howells, and V.A. Russell Effects of early life trauma are dependent on genetic predisposition: a rat study Behav. Brain Funct. 7 2011 1 7
89. E.A. Stone, Y. Zhang, H. Rosengarten, J. Yeretsian, and D. Quartermain Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice Neuroscience 94 1999 1245 1252 (Pubitemid 29509689)
90. 3H] prazosin binding is correlated with behavioral immobility Eur. J. Pharmacol. 420 2001 97 102 (Pubitemid 32537683)
91. E.A. Stone, L.I.N. Yan, M.R. Ahsan, M.L. Lehmann, J. Yeretsian, and D. Quartermain Role of CNS alpha-1-adrenoceptor activity in central fos responses to novelty Synapse 59 2006 299 307 (Pubitemid 43271738)
92. E.A. Stone, Y. Lin, Y. Sarfraz, and D. Quartermain The role of the central noradrenergic system in behavioral inhibition Brain Res. Rev. 67 2011 193 208
93. J. Swanson, R.D. Baler, and N.D. Volkow Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress Neuropsychopharmacology 36 2010 207 226
94. V. Valentini, R. Frau, and G.D. Chiara Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine J. Neurochem. 88 2004 917 927 (Pubitemid 38199313)
95. A. Valjakka, J. Sirvio, and P. Riekkinen The effects of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity, and reaction to novelty Behav. Neural Biol. 54 1990 323 329 (Pubitemid 20365796)
96. L. Velley, E. Kempf, and B. Cardo Locomotor activity of rats after stimulation of the nucleus locus coeruleus region or after lesion of the dorsal noradrenergic bundle: effects of clonidine, prazosin and yohimbine Psychopharmacology (Berl) 78 1982 239 244 (Pubitemid 13250850)
97. A.A. Walf, and C.A. Frye The use of the elevated plus maze as an assay of anxiety-related behaviour in rodents Nat. Protoc. 2 2007 322 328 (Pubitemid 47040046)
98. R. Walsh, and R. Cummins The open-field test: a critical review Psychol. Rep. 83 1976 482 504
99. K.J. Watling, M.S. Beer, J.A. Stanton, and N.R. Newberry Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat Eur. J. Pharmacol. 182 1990 465 472 (Pubitemid 20260764)
100. H. Weigmann, S. Hartter, V. Fischer, N. Dahmen, and C. Hiemke Distribution of clozapine and desmethylclozapine between blood and brain in rats Eur. Neuropsychopharmacol. 9 1999 253 256 (Pubitemid 29114932)
101. I.C. Weiss, C.R. Pryce, A.L. Jongen-r, N.I. Nanz-bahr, and J. Feldon Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat Behav. Brain Res. 152 2004 279 295 (Pubitemid 38757899)
102. B.H.C. Westerink, P.D. Boer, J.B.D. Vries, C.G. Kruse, and S.K. Long Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain Eur. J. Pharmacol. 1998 27 33 (Pubitemid 28522155)
103. K.D. Youngren, F.M. Inglis, P.J. Pivirotto, H.P. Jedema, C.W. Bradberry, P.S. Goldman-Rakic, R.H. Roth, and B. Moghaddam Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus Neuropsychopharmacology 20 1999 403 412 (Pubitemid 29123868)
104. K. Zhang, F.I. Tarazi, and R.J. Baldessarini Role of dopamine D4 receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats Neuropsychopharmacology 25 2001 624 632 (Pubitemid 32995944)